Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.

Miskowiak KW, Vinberg M, Harmer CJ, Ehrenreich H, Knudsen GM, Macoveanu J, Hansen AR, Paulson OB, Siebner HR, Kessing LV.

Trials. 2010 Oct 13;11:97. doi: 10.1186/1745-6215-11-97.

2.

Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial.

Miskowiak KW, Vinberg M, Christensen EM, Bukh JD, Harmer CJ, Ehrenreich H, Kessing LV.

Neuropsychopharmacology. 2014 May;39(6):1399-408. doi: 10.1038/npp.2013.335. Epub 2013 Dec 10.

3.
4.

Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial.

Miskowiak KW, Ehrenreich H, Christensen EM, Kessing LV, Vinberg M.

J Clin Psychiatry. 2014 Dec;75(12):1347-55. doi: 10.4088/JCP.13m08839.

PMID:
25099079
5.

Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.

Torrent C, Martinez-Arán A, Daban C, Amann B, Balanzá-Martínez V, del Mar Bonnín C, Cruz N, Franco C, Tabarés-Seisdedos R, Vieta E.

Compr Psychiatry. 2011 Nov-Dec;52(6):613-22. doi: 10.1016/j.comppsych.2010.12.009. Epub 2011 Feb 4.

PMID:
21295774
6.

Effects of Erythropoietin on Hippocampal Volume and Memory in Mood Disorders.

Miskowiak KW, Vinberg M, Macoveanu J, Ehrenreich H, Køster N, Inkster B, Paulson OB, Kessing LV, Skimminge A, Siebner HR.

Biol Psychiatry. 2015 Aug 15;78(4):270-7. doi: 10.1016/j.biopsych.2014.12.013. Epub 2014 Dec 18.

PMID:
25641635
7.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
8.

Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.

Miskowiak KW, Favaron E, Hafizi S, Inkster B, Goodwin GM, Cowen PJ, Harmer CJ.

Psychopharmacology (Berl). 2009 Nov;207(1):133-42. doi: 10.1007/s00213-009-1641-1. Epub 2009 Aug 25.

PMID:
19705104
9.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
10.

Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study.

Xu G, Lin K, Rao D, Dang Y, Ouyang H, Guo Y, Ma J, Chen J.

J Affect Disord. 2012 Feb;136(3):328-39. doi: 10.1016/j.jad.2011.11.029. Epub 2011 Dec 12.

PMID:
22169253
11.

A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder.

McIntyre RS, Soczynska JK, Woldeyohannes HO, Miranda A, Vaccarino A, Macqueen G, Lewis GF, Kennedy SH.

Bipolar Disord. 2012 Nov;14(7):697-706. doi: 10.1111/bdi.12006.

PMID:
23107220
12.
13.

[Gender differences in the neurocognitive components of depression].

Sárosi A, Gonda X, Balogh G, Székely A, Sasvári M, Faludi G.

Neuropsychopharmacol Hung. 2008 Oct;10(4):191-9. Hungarian.

14.

Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.

Chengappa KN, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R.

J Clin Psychiatry. 2013 Nov;74(11):1076-83. doi: 10.4088/JCP.13m08413.

15.

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder.

Young AH, Gallagher P, Watson S, Del-Estal D, Owen BM, Ferrier IN.

Neuropsychopharmacology. 2004 Aug;29(8):1538-45.

16.

Psychosocial and neurocognitive profiles in depressed patients with major depressive disorder and bipolar disorder.

Godard J, Grondin S, Baruch P, Lafleur MF.

Psychiatry Res. 2011 Dec 30;190(2-3):244-52. doi: 10.1016/j.psychres.2011.06.014. Epub 2011 Jul 18.

PMID:
21764461
17.

Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.

Khin NA, Chen YF, Yang Y, Yang P, Laughren TP.

J Clin Psychiatry. 2011 Apr;72(4):464-72. doi: 10.4088/JCP.10m06191. Erratum in: J Clin Psychiatry. 2011 Jun;72(6):874.

PMID:
21527123
18.

Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales.

Luckenbaugh DA, Ameli R, Brutsche NE, Zarate CA Jr.

J Psychiatr Res. 2015 Feb;61:40-5. doi: 10.1016/j.jpsychires.2014.12.015. Epub 2014 Dec 27.

19.

Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study.

Vinberg M, Weikop P, Olsen NV, Kessing LV, Miskowiak K.

Brain Behav Immun. 2016 Oct;57:53-7. doi: 10.1016/j.bbi.2016.05.006. Epub 2016 May 12.

PMID:
27181179
20.

Stability and course of neuropsychological deficits in manic and depressed bipolar patients compared to patients with Major Depression.

Gruber S, Rathgeber K, Bräunig P, Gauggel S.

J Affect Disord. 2007 Dec;104(1-3):61-71. Epub 2007 Mar 23.

PMID:
17360041
Items per page

Supplemental Content

Write to the Help Desk